Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine and Gemcitabine in Advanced NSCLC
NCT00077415Phase 2Completed
- Sponsor
- Cancer Therapeutics Research Group
- Start
- Apr 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of triapine in non-small cell lung cancer (NSCLC), sponsored by Cancer Therapeutics Research Group. Started Apr 2004; status: completed.
02
Drugs
triapine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00077415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00077415.